Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Merck
Moodys
McKesson
Johnson and Johnson

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Litigation Details for Mass Engineered Design, Inc. v. Planar Systems, Inc. (D. Or. 2016)

See Plans and Pricing

« Back to Dashboard

Mass Engineered Design, Inc. v. Planar Systems, Inc. (D. Or. 2016)

Docket   Start Trial Date Filed 2016-07-26
Court District Court, D. Oregon Date Terminated
Cause 15:1126 Patent Infringement Assigned To Michael Howard Simon
Jury Demand Both Referred To
Parties MASS ENGINEERED DESIGN, INC.; MOUNT SPELMAN P.C.; PLANAR SYSTEMS, INC.
Patents 10,029,011; 8,039,009
Attorneys Andrew T Oliver; Andrew T. Oliver; Andrew W. Spangler; Jacob S. Gill; Jenny W. Chen; Jenny Wei-Chun Chen; Jing Hong Cherng; John J Edmonds; John J. Edmonds; Johnathan E. Mansfield; Shea Neal Palavan; Stephen F Schlather; Stephen F. Schlather
Link to Docket External link to docket
Small Molecule Drugs cited in Mass Engineered Design, Inc. v. Planar Systems, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Mass Engineered Design, Inc. v. Planar Systems, Inc. (D. Or. 2016)

Date Filed Document No. Description Snippet Link To Document
2016-08-29 54 Transcript of Proceedings ] 7/6 12/3 13/8 13/11 20/3 unreasonably [3] 29/10 29/11 29/22 … the few patent cases that I've had. I have not had 16 that many patent cases, but… decisions on comparable patents, or at least the same 11 '978 patent, from the Ergotron case, …perspectives, as experienced 12 patent litigators, I don't think for patent litigation it is a 13 particularly…disputes. 20 I think patent litigation, maybe patent litigation/ 21 antitrust litigation External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Dow
AstraZeneca
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.